AMENDMENT NO. 1 TO2013 Securities Purchase Agreement • February 6th, 2014 • Champions Oncology, Inc. • Biological products, (no disgnostic substances)
This Amendment No. 1 (this “Amendment”), dated as of January 29, 2014, is by and among Champions Oncology, Inc. (the “Company”), Battery Ventures IX, L.P. (“Ventures”), Battery Investment Partners IX, LLC (together with Ventures, “Battery”) and PAR Investment Partners, L.P. (“PAR”).
AMENDED AND RESTATED 2013 SECURITIES PURCHASE AGREEMENT2013 Securities Purchase Agreement • March 17th, 2015 • Champions Oncology, Inc. • Biological products, (no disgnostic substances) • New York
This AMENDED AND RESTATED 2013 SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of March 13, 2015, by and between Champions Oncology, Inc., a Delaware corporation (the “Company”), Battery Ventures IX, L.P., a Delaware limited partnership (“Ventures”), Battery Investment Partners IX, LLC, a Delaware limited liability company (together with Ventures, “Battery”), PAR Investment Partners, L.P., a Delaware limited partnership (“PAR”), Joel Ackerman (“Ackerman”) and Ronnie Morris (“Morris”) amends and restates in its entirety the Securities Purchase Agreement dated as of January 28, 2013 (the “Original 2013 Securities Purchase Agreement”) between the Company, Battery, PAR, Ackerman, Morris and the other parties to the Original 2013 Securities Purchase Agreement (such parties, Battery, PAR, Ackerman and Morris being the “Investors”), as amended by the Amendment No. 1 to 2013 Securities Purchase Agreement dated January 29, 2014.
